Physician profile
Sameet Shah
NPI 1912311606
$1,224.13
in general payments reported to CMS, 2019-2025
12 companies · $506 in 2025
The $506 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2021: $82.33 · 2022: $91.91 · 2023: $196 · 2024: $118 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $422.11 | 2021-2025 | Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $172.02 | 2021-2025 | Entyvio, Eohilia, Gattex |
| Pfizer INC. | $148.43 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $112.55 | 2021-2025 | Xifaxan, Plenvu |
| Boston Scientific Corporation | $109.32 | 2019 | |
| Janssen Biotech, INC. | $86.26 | 2022-2025 | Tremfya, Simponi Aria, Remicade |
| Madrigal Pharmaceuticals | $45.84 | 2025 | Rezdiffra |
| Braintree Laboratories, INC. | $41.36 | 2022-2025 | Suflave |
| Phathom Pharmaceuticals, INC. | $31.69 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $27.78 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $14.37 | 2023 | |
| Celgene Corporation | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameet Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.